You are here
Spineology Announces FDA Clearance of Rampart™ Duo™ Interbody Fusion System
ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology, Inc. the innovator in anatomy-conserving surgery™, is excited to announce FDA clearance of the Rampart Duo Interbody Fusion System. The Rampart Duo Interbody Fusion Device is the first device of its kind to combine PEEK, titanium, and graft containment mesh elements.
“The device has been anatomically designed. The PEEK spacer blocks are positioned on the lateral aspects of the vertebral body, where the bone is naturally strongest, to provide solid anterior support,” adds Dr. Michael Wang, Miami, FL. “In addition, the central graft containment mesh allows for broad device deployment which increases graft footprint and facilitates conforming apposition of the graft to the endplate for fusion.”
“The small tubular retractor and streamlined instruments, including ones that allow for the placement of the device when a high iliac crest is present, may help preserve patient anatomy and limit operating room time,” said Dr. Craig Kuhns, Austin, TX.
The Rampart Duo implant design includes PEEK spacer blocks that are positioned at each end of the device and a flexible porous graft containment mesh which creates a central graft cavity. Following implantation, the porous graft containment mesh is filled with bone graft to deploy the device in the anterior-posterior direction, which allows for a wide graft footprint, and in the superior-inferior direction to provide conforming apposition with the vertebral endplates.